InvestSMART

Profit inroads for API

Australian Pharmaceutical Industries has reported net profit of $12.9 million for the first six months of its fiscal year, down 29.8 per cent on the previous corresponding period. But the previous result was boosted by $14.5 million in insurance proceeds. Underlying net profit, which excludes one-off items, rose 6.8 per cent. Sales were flat at $1.6 billion.
By · 19 Apr 2013
By ·
19 Apr 2013
comments Comments
Australian Pharmaceutical Industries has reported net profit of $12.9 million for the first six months of its fiscal year, down 29.8 per cent on the previous corresponding period. But the previous result was boosted by $14.5 million in insurance proceeds. Underlying net profit, which excludes one-off items, rose 6.8 per cent. Sales were flat at $1.6 billion.
Google News
Follow us on Google News
Go to Google News, then click "Follow" button to add us.
Share this article and show your support
Free Membership
Free Membership
InvestSMART
InvestSMART
Keep on reading more articles from InvestSMART. See more articles
Join the conversation
Join the conversation...
There are comments posted so far. Join the conversation, please login or Sign up.

Frequently Asked Questions about this Article…

API reported a net profit of $12.9 million for the first six months of its fiscal year.

The reported net profit fell 29.8% compared with the previous corresponding period largely because last year’s result was boosted by $14.5 million in insurance proceeds, which did not recur.

Underlying net profit excludes one‑off or non‑recurring items (like insurance payouts) to show operational performance. API’s underlying net profit rose by 6.8% in the half.

Sales were flat year‑on‑year at $1.6 billion for the six‑month period, indicating revenue stability over the prior corresponding period.

Reported net profit can be affected by one‑off items (for example, insurance proceeds), so underlying net profit gives a clearer view of ongoing business performance. In API’s case, reported profit fell while underlying profit rose, signalling stronger core operations despite the headline decline.

Yes. The previous corresponding period included $14.5 million in insurance proceeds, which materially boosted that year’s reported profit and contributed to this year’s reported fall.

Flat sales at $1.6 billion alongside a 6.8% rise in underlying net profit suggests API improved underlying profitability or cost management during the half, even though top‑line growth was steady rather than increasing.

Investors typically watch whether underlying profit growth continues, if sales move beyond a flat $1.6 billion, and whether any further one‑off items occur. These factors will help determine if the improvement in operational earnings is sustainable.